The future of patient-derived xenografts in prostate cancer research
Nature Reviews Urology, Published online: 17 January 2023; doi:10.1038/s41585-022-00706-xThis Perspective covers existing patient-derived xenografts (PDXs) of prostate cancer, and their features and uses in basic and preclinical research. The authors also discuss the need for additional PDXs, and how collaboration in prostate cancer PDX research can be improved.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Mitchell G. Lawrence Renea A. Taylor Georgia B. Cuffe Lisa S. Ang Ashlee K. Clark David L. Goode Laura H. Porter Cl émentine Le Magnen Nora M. Navone Jack A. Schalken Yuzhuo Wang Wytske M. van Weerden Eva Corey John T. Isaacs Peter S. Nelson Gail P. Risb Source Type: research
More News: Cancer | Cancer & Oncology | Georgia Health | Legislation | Men | Prostate Cancer | Urology & Nephrology